Thales, Boeing, QinetiQ team on UAV for MOD
Article Abstract:
Thales UK, the Boeing Co., and QinetiQ received a U.K. Ministry of Defence (MOD) contract for unmanned aerial vehicle (UAV) work. The MOD program is an example about how the military forces around the globe are turning to UAVs as a means of accomplishing missions without placing men and women in difficult situation.
Publication Name: Defense Today
Subject: Business
ISSN:
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Sikorsky Aircraft says Black Hawk deliveries to resume in a week
Article Abstract:
The company spokesman of Sikorsky Helicopter Corp. stated that the company expects to resume its delivery of H-60 series, Black Hawk and Seahawk helicopters. Plans are proposed to correct problems like leaky gearboxes and bolts with threads stripped away to rapidly get the Black Hawk program back on track.
Publication Name: Defense Today
Subject: Business
ISSN:
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Homeland security: Radiation, other sensors aid military, first responders
Article Abstract:
Thermo-Electron, Inc. and VivoMetrics, Inc. are providing systems that can monitor first-responder and military personnel exposure to radiation and other threats. The system is worn below hazmat protective gear will monitor the vital signs of the personnel and help locate them in the event of a hazard.
Publication Name: Defense Today
Subject: Business
ISSN:
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Global Hawk UAV readies for new sensors. Sirorsky claims safety edge in PRV bid. Northrop Grumman sees global hawk as 'computer'
- Abstracts: FCA partnership to seek more DOD aircraft business. Firm to show DoD brass new Humvee cooling system
- Abstracts: Boeing reports mixed bag of military aircraft sales. Boeing probes seen continuing, but not harming revenues
- Abstracts: Tweedie on board for five more years. What women want. Blossoming Menzies
- Abstracts: Pharma consolidates its grip on post-antibody landscape. Lack of data mires Aranesp in controversy